Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) - non-interventional study.

Losem C, Koenigsmann M, Rudolph C.

Onco Targets Ther. 2017 Feb 28;10:1295-1305. doi: 10.2147/OTT.S122427. eCollection 2017.

2.

Cardiac function during resuscitation from hemorrhagic shock with polymerized bovine hemoglobin-based oxygen therapeutic.

Ao-Ieong ES, Williams A, Jani V, Cabrales P.

Artif Cells Nanomed Biotechnol. 2017 Jun;45(4):686-693. doi: 10.1080/21691401.2016.1241797. Epub 2016 Nov 24.

PMID:
27881020
3.

Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients.

Kurtz JE, Soubeyran P, Michallet M, Luporsi E, Albrand H.

Onco Targets Ther. 2016 Oct 28;9:6689-6693. eCollection 2016.

4.

Acute kidney function and morphology following topload administration of recombinant hemoglobin solution.

Martucci AF, Abreu Martucci AC, Cabrales P, Nascimento PD Jr, Intaglietta M, Tsai AG, Castiglia YM.

Artif Cells Nanomed Biotechnol. 2017 Feb;45(1):24-30. Epub 2016 Oct 31.

5.

An Analysis of and Recommendations for the Peruvian Blood Collection and Transfusion System.

George PE, Vidal J, Garcia PJ.

J Epidemiol Public Health Rev. 2016 May;1(3). doi: 10.16966/2471-8211.119. Epub 2016 Apr 22.

6.

Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.

Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT, Pelletier W, Perkins JL, Rivard LS, Schechter T, Shah AJ, Wilson KD, Wong K, Grewal SS, Armenian SH, Meacham LR, Mulrooney DA, Castellino SM.

Biol Blood Marrow Transplant. 2016 May;22(5):782-95. doi: 10.1016/j.bbmt.2016.01.023. Epub 2016 Jan 21. Review.

7.

Prospective randomised evaluation of a collagen/thrombin and autologous platelet haemostatic agent during cementless total hip arthroplasty.

Joyce DM, Klika AK, Mutnal A, Krebs V, Molloy R, Knothe U, Barsoum WK.

Blood Transfus. 2015 Jul;13(3):455-63. doi: 10.2450/2015.0291-14. Epub 2015 Apr 21.

8.

A fatal case of post-transfusion sepsis caused by Yersinia enterocolitica after delivery.

Frati P, Busardò FP, Di Stefano MA, Neri M, Sessa F, Fineschi V.

Blood Transfus. 2015 Jul;13(3):528-31. doi: 10.2450/2015.0209-14. Epub 2015 Jan 26. No abstract available.

9.

Replacing the Transfusion of 1-2 Units of Blood with Plasma Expanders that Increase Oxygen Delivery Capacity: Evidence from Experimental Studies.

Tsai AG, Salazar Vázquez BY, Cabrales P, Kistler EB, Tartakovsky DM, Subramaniam S, Acharya SA, Intaglietta M.

J Funct Biomater. 2014 Oct 27;5(4):232-45. doi: 10.3390/jfb5040232. Review.

10.

Screening tests: a review with examples.

Maxim LD, Niebo R, Utell MJ.

Inhal Toxicol. 2014 Nov;26(13):811-28. doi: 10.3109/08958378.2014.955932. Epub 2014 Sep 29. Review.

11.

BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study.

Michallet M, Luporsi E, Soubeyran P, Amar NA, Boulanger V, Carreiro M, Dourthe LM, Labourey JL, Lepille D, Maloisel F, Mouysset JL, Nahon S, Narciso B, Nouyrigat P, Radji R, Sakek N, Albrand H; ORHEO study group.

BMC Cancer. 2014 Jul 10;14:503. doi: 10.1186/1471-2407-14-503. Erratum in: BMC Cancer. 2014;14:720.

12.
13.

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Siberry GK, Abzug MJ, Nachman S, Brady MT, Dominguez KL, Handelsman E, Mofenson LM, Nesheim S; Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children, National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, American Academy of Pediatrics.

Pediatr Infect Dis J. 2013 Nov;32 Suppl 2:i-KK4. doi: 10.1097/01.inf.0000437856.09540.11. No abstract available.

14.

Inflammatory response to trauma: implications for coagulation and resuscitation.

Pierce A, Pittet JF.

Curr Opin Anaesthesiol. 2014 Apr;27(2):246-52. doi: 10.1097/ACO.0000000000000047. Review.

15.

Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis.

Keyvani H, Bokharaei-Salim F, Monavari SH, Esghaei M, Nassiri Toosi M, Fakhim S, Sadigh ZA, Alavian SM.

Hepat Mon. 2013 Aug 5;13(8):e11290. doi: 10.5812/hepatmon.11290. eCollection 2013.

16.

Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Cabrales P, Intaglietta M.

ASAIO J. 2013 Jul-Aug;59(4):337-54. doi: 10.1097/MAT.0b013e318291fbaa. Review.

17.

Plasma in the PICU: why and when should we transfuse?

Labarinas S, Arni D, Karam O.

Ann Intensive Care. 2013 Jun 2;3(1):16. doi: 10.1186/2110-5820-3-16.

18.

Examining and mitigating acellular hemoglobin vasoactivity.

Cabrales P.

Antioxid Redox Signal. 2013 Jun 10;18(17):2329-41. doi: 10.1089/ars.2012.4922. Epub 2012 Oct 11. Review.

19.

Reducing the risk of hepatitis B virus transfusion-transmitted infection.

Niederhauser C.

J Blood Med. 2011;2:91-102. doi: 10.2147/JBM.S12899. Epub 2011 Jul 18.

20.

Low frequency of occult hepatitis B infection in anti-HBc seropositive blood donors: experience from a tertiary care centre in South India.

Ismail AM, Devakumar S, Anantharam R, Fletcher GJ, Subramani T, John GT, Daniel D, Abraham P.

Blood Transfus. 2012 Apr;10(2):230-2. doi: 10.2450/2011.0046-11. Epub 2011 Nov 15. No abstract available.

Supplemental Content

Support Center